In the second trial, which was open label, 95.6% of participants who switched to DOR/ISL maintained viral suppression ...

Merck (MRK) announced the presentation of “positive” results from two pivotal Phase 3 trials of the investigational, once-daily, oral, two-drug ...

Unveiling of the new factory comes as Merck and other pharma companies face pressure to reshore manufacturing back to the U.S ...

Why is China the Talk of the Town […] On Wednesday, Merck & Co Inc (NYSE:MRK) announced the presentation of results from two Phase 3 trials of doravirine/islatravir (DOR/ISL) in adults with HIV ...

Merck KGaA is shaping up to take on Daiichi Sankyo and Ono Pharma in the market for tenosynovial giant cell tumour (TGCT) therapies after its drug candidate pimicotinib cleared a phase 3 trial.

The news came in a brief statement, which followed a surprise success for anacetrapib in the large multi-billion dollar phase 3 REVEAL trial earlier this year. Merck & Co was the last big pharma ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

"The Wheel of Time" season 3 is finally here this week. "The Rings of Power" season 2 has been and gone, meaning we're now looking ahead to Prime Video's other major fantasy saga. The show was ...

After hours: March 13 at 7:59:21 PM EDT Loading Chart for MRK ...